| THE PHARMACOLOGY. METABOLISM. ANALYSIS. AND APPLICATIONS OF COMPOUNDS RD Egan, D. O'Kennedy, R. Moran, E. Cox, D. Prosser, E. Thornes Drug metabolism reviews 22 (5), 503-529, 1990 | 706* | 1990 |
| Integrins as therapeutic targets: lessons and opportunities D Cox, M Brennan, N Moran Nature reviews Drug discovery 9 (10), 804-820, 2010 | 599 | 2010 |
| The interaction of bacterial pathogens with platelets JR Fitzgerald, TJ Foster, D Cox Nature Reviews Microbiology 4 (6), 445-457, 2006 | 575 | 2006 |
| Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine–aspartate repeat protein … SW O'Brien, L, Kerrigan, G Kaw, M Hogan, J Penadés, D Litt, ... Molecular microbiology 44 (4), 1033-1044, 2002 | 384 | 2002 |
| Platelets and the innate immune system: mechanisms of bacterial‐induced platelet activation D Cox, SW Kerrigan, SP Watson Journal of Thrombosis and Haemostasis 9 (6), 1097-1107, 2011 | 360 | 2011 |
| Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers D Cox, AO Maree, M Dooley, R Conroy, MF Byrne, DJ Fitzgerald Stroke 37 (8), 2153-2158, 2006 | 341 | 2006 |
| Cyclooxygenase‐1 haplotype modulates platelet response to aspirin AO Maree, RJ Curtin, A Chubb, C Dolan, D Cox, J O'brien, P Crean, ... Journal of Thrombosis and Haemostasis 3 (10), 2340-2345, 2005 | 327 | 2005 |
| Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease AO Maree, RJ Curtin, M Dooley, RM Conroy, P Crean, D Cox, ... Journal of the American College of Cardiology 46 (7), 1258-1263, 2005 | 325 | 2005 |
| Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation MF Byrne, SW Kerrigan, PA Corcoran, JC Atherton, FE Murray, ... Gastroenterology 124 (7), 1846-1854, 2003 | 251 | 2003 |
| Fibronectin‐binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG … JR Fitzgerald, A Loughman, F Keane, M Brennan, M Knobel, J Higgins, ... Molecular microbiology 59 (1), 212-230, 2006 | 235 | 2006 |
| A serine‐rich glycoprotein of Streptococcus sanguis mediates adhesion to platelets via GPIb C Plummer, H Wu, SW Kerrigan, G Meade, D Cox, CW Ian Douglas British journal of haematology 129 (1), 101-109, 2005 | 230 | 2005 |
| Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A A Loughman, JR Fitzgerald, MP Brennan, J Higgins, R Downer, D Cox, ... Molecular microbiology 57 (3), 804-818, 2005 | 227 | 2005 |
| The pharmacology of the integrins D Cox, T Aoki, J Seki, Y Motoyama, K Yoshida Medicinal Research Reviews 14 (2), 195-228, 1994 | 190 | 1994 |
| Amplification of bacteria-induced platelet activation is triggered by FcγRIIA, integrin αIIbβ3, and platelet factor 4 M Arman, K Krauel, DO Tilley, C Weber, D Cox, A Greinacher, ... Blood, The Journal of the American Society of Hematology 123 (20), 3166-3174, 2014 | 176 | 2014 |
| Staphylococcus aureus protein A binding to von Willebrand factor A1 domain is mediated by conserved IgG binding regions M O'Seaghdha, CJ van Schooten, SW Kerrigan, J Emsley, GJ Silverman, ... The FEBS journal 273 (21), 4831-4841, 2006 | 173 | 2006 |
| A role for glycoprotein Ib in Streptococcus sanguis–induced platelet aggregation SW Kerrigan, I Douglas, A Wray, J Heath, MF Byrne, D Fitzgerald, D Cox Blood, The Journal of the American Society of Hematology 100 (2), 509-516, 2002 | 164 | 2002 |
| The role of platelets in the pathogenesis of viral hemorrhagic fevers JC Zapata, D Cox, MS Salvato PLoS Neglected Tropical Diseases 8 (6), e2858, 2014 | 160 | 2014 |
| Evidence of platelet activation during treatment with a GPIIb/IIIa antagonist in patients presenting with acute coronary syndromes D Cox, R Smith, M Quinn, P Theroux, P Crean, DJ Fitzgerald Journal of the American College of Cardiology 36 (5), 1514-1519, 2000 | 155 | 2000 |
| Platelet–bacterial interactions SW Kerrigan, D Cox Cellular and Molecular Life Sciences 67, 513-523, 2010 | 154 | 2010 |
| The rarity of liver toxicity in patients treated with coumarin (1, 2-benzopyrone) D Cox, R O'kennedy, RD Thornes Human toxicology 8 (6), 501-506, 1989 | 134 | 1989 |
Steven W. KerriganProfessor of Precision Therapeutics, RCSI University of Medicine and在 rcsi.ie 的电子邮件经过验证
